Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q77843547)
Watch
English
FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
scientific article published on 01 June 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
title
FLAG (fludarabine, high-dose cytarabine, and G-CSF) for refractory and high-risk relapsed acute leukemia in children
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
main subject
cytarabine
1 reference
based on heuristic
inferred from title
acute leukemia
1 reference
based on heuristic
inferred from title
author name string
A J McCarthy
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
L A Pitcher
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
I M Hann
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
A Oakhill
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
publication date
1 June 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
published in
Pediatric Blood & Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
volume
32
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
issue
6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
page(s)
411-415
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
cites work
Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
The expanding role of fludarabine in hematologic malignancies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Treatment of relapsed adult acute lymphoblastic leukemia with fludarabine and cytosine arabinoside followed by granulocyte colony-stimulating factor (FLAG-GCSF)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia Pediatrica
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Phase I and II study of fludarabine phosphate in leukemia: therapeutic efficacy with delayed central nervous system toxicity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without gran
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
IDA-FLAG (idarubicin, fludarabine, high dosage cytarabine and G-CSF)--an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Impact of reinduction regimens for relapsed and refractory acute lymphoblastic leukemia in adults
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
High-dose cytosine arabinoside and L-asparaginase in refractory acute lymphoblastic leukemia: the Children's Cancer Group experience
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Fludarabine for prolymphocytic leukaemia and risk of interstitial pneumonitis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Pulmonary toxicity and acute respiratory failure associated with fludarabine monophosphate
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199906%2932%3A6%3C411%3A%3AAID-MPO3%3E3.0.CO%3B2-K
retrieved
21 January 2018
Identifiers
DOI
10.1002/(SICI)1096-911X(199906)32:6<411::AID-MPO3>3.0.CO;2-K
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
PubMed publication ID
10358698
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10358698
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10358698%20AND%20SRC:MED&resulttype=core&format=json
retrieved
8 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit